Gazprom, the Russian multinational energy company, has sold its Austrian trading division along with its Italian subsidiary to the investment company EGH Gulf, which was recently established in Dubai.

Eli Lilly has signed another bolt-on deal to bulk up its pipeline, this time paying $47.5 million upfront for rights to a non-opioid analgesic drug developed by US biotech Centrexion Therapeutics. Add ...